(Press-News.org) A new diagnostic method, namely spectral histopathology, facilitates marker-free detection of individual subtypes of lung cancers. It was developed by researchers at the PURE consortium at Ruhr-Universität Bochum (RUB). They have successfully applied it in collaboration with clinicians at the Ruhrlandklinik in Essen. It is an automatable imaging process which, by classifying specific forms of lung cancer, facilitates a prognosis regarding a tumour's aggressiveness. The team, headed by RUB Prof Dr Klaus Gerwert, compares the results of traditional diagnostic procedures with those of spectral histopathology in the journal Analyst.
Comparison with traditional tumour detection methods: specific treatment of patients
"Distinguishing between different subtypes of lung cancer is essential for making a prognosis regarding the progression of the disease," explains Klaus Gerwert from the protein research consortium PURE (Protein Research Unit Ruhr within Europe). "The precise diagnosis of tumour subtypes enables doctors to deploy personalised medicine and conducting a more target-specific and therefore more successful therapy in future." The research team compared the results gained through spectral histopathology (SHP) with those of traditional histological diagnostics. "Our results match the pathologists' diagnosis perfectly," says Dr Angela Kallenbach-Thieltges. "Accordingly, it has been an impressive demonstration of the method's potential for clinical diagnostics." The accuracy of SHP for detecting lung cancer subtypes (adenocarcinoma) is higher than 92 per cent, compared with traditional histopathology. Further studies with larger patient cohorts are still required to validate the method. "In future, we want to optimise the system and adapt it for other symptoms," adds Dr Frederik Großerüschkamp.
Dyeing of tissue sections not required for spectral histopathology
Unlike the methods available to date, SHP, which is now fully established at the RUB Department of Biophysics, does not require the tissue to be dyed with various markers in order to identify the cancer subtype. Pathologists commonly diagnose lung cancer by conducting a microscopic analysis of dyed thin tissue sections from a lung biopsy. Frequently, a diagnose cannot be made until an advanced stage, because the symptoms only appear once the disease is very progressed. Spectral histopathology, on the other hand, detects molecular changes to the tissue directly, especially protein changes, without any dyeing being necessary. As it operates with light rays, the thin tissue section from the biopsy can subsequently be examined with other methods, especially genome or proteome analyses.
Application in operating theatre possible
The SHP results can assist surgeons in making therapeutic decisions on the spot during a surgery. To this end, it has to be possible to deploy a spectral histopathology probe in the operating theatre. Moreover, the data could in future provide pathologists with a "second opinion" to aid their decision-making processes. In earlier studies, the PURE team tested SHP for colorectal cancer diagnosis. This is how SHP works in detail: http://aktuell.ruhr-uni-bochum.de/pm2013/pm00265.html.en.
INFORMATION:
Project backing and partners
Project funds are provided by Deutsche gesetzliche Unfallversicherung (DGUV; Project FP339A). It was conducted by IPA in collaboration with the team headed by Prof Dr Thomas Brüning.
Bibliographic record
F. Großerueschkamp, A. Kallenbach-Thieltges, T. Behrens, T. Brüning, M. Altmayer, G. Stamatis, D. Theegarten, K. Gerwert (2015): Marker-free automated histopathological annotation of lung tumour subtypes by FTIR imaging, Analyst, DOI: 10.1039/C4AN01978D
Further information
Prof Dr Klaus Gerwert, Department of Biophysics, Faculty of Biology and Biotechnology at Ruhr-Universität, 44780 Bochum, Germany, phone: +49/234/32-24461, gerwert@bph.rub.de
Image online
An images related to this press release can be found online:
http://aktuell.ruhr-uni-bochum.de/pm2015/pm00053.html.en
CLEMSON, S.C. -- In a groundbreaking achievement led by an international team that includes Clemson scientist Chris Saski, the intricately woven genetic makeup of Upland cotton has been decoded for the first time in the ancient plant's history.
Saski participated in sequencing the genome, which is a crucial stepping-stone toward further advancements of understanding the inner workings of one of the most complex and treasured plants on the planet.
The future implications of Saski's research in the short and long terms are both financial and holistic. Upland cotton, which ...
CORVALLIS, Ore. - Researchers at Oregon State University have invented a new technology that can increase the bandwidth of WiFi systems by 10 times, using LED lights to transmit information.
The technology could be integrated with existing WiFi systems to reduce bandwidth problems in crowded locations, such as airport terminals or coffee shops, and in homes where several people have multiple WiFi devices.
Experts say that recent advances in LED technology have made it possible to modulate the LED light more rapidly, opening the possibility of using light for wireless ...
NEW YORK (April 20, 2015) -- Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
The study, published April 20 in Nature Communications, suggests that global changes in cancer ...
A rigorous analysis of antimalarial drug quality conducted in Cambodia and Tanzania found no evidence of fake medicines, according to new research published in the American Journal of Tropical Medicine and Hygiene.
But researchers warn that routine surveillance is crucial as poor quality medicines exist, leaving malaria patients at risk of dying and increasing the risk of drug resistance.
Previous reports had suggested that up to one third of antimalarials could be fake. Researchers from the Artemisinin-based Combination Therapy (ACT) Consortium at the London School ...
Dispensing of prescription opioid pain relievers and prescription opioid overdoses both dropped substantially after abuse-deterrent extended-release oxycodone hydrochloride was introduced on the pharmaceutical market and the narcotic drug propoxyphene was withdrawn from the U.S. market in 2010, according to an article published online by JAMA Internal Medicine.
The abuse-deterrent OxyContin formulation is resistant to crushing and dissolving, actions that have been used to bypass the extended-release mechanism to get a quicker and more intense high. Propoxyphene (also ...
Children whose families and pediatricians were most faithful to an obesity intervention program that included computerized clinical decision support for physicians and health coaching for families experienced the greatest improvements in body mass index (BMI), according to an article published online by JAMA Pediatrics.
The prevalence of childhood obesity in the United States remains at historically high levels. Clinical approaches that are cost-effective and scalable for obesity reduction in children are a public health priority. However, interventions to improve BMI ...
(Boston) - Results of a new study led by Boston Medical Center (BMC) researchers, in collaboration with Harvard Medical School (HMS), indicate that the introduction of abuse-deterrent OxyContin, coupled with the removal of propoxyphene from the US prescription marketplace, may have played a role in decreasing opioid prescribing and overdoses. The findings, published in JAMA Internal Medicine, showed that these two changes led to a 19 percent drop in prescription opioid supply that was mirrored by a 20 percent drop in prescription opioid overdose between August 2010 and ...
Poor quality medicines are a real and urgent threat that could undermine decades of successful efforts to combat HIV/AIDS, malaria and tuberculosis, according to the editors of a collection of journal articles published today. Scientists report up to 41 percent of specimens failed to meet quality standards in global studies of about 17,000 drug samples. Among the collection is an article describing the discovery of falsified and substandard malaria drugs that caused an estimated 122,350 deaths in African children in 2013. Other studies identified poor quality antibiotics, ...
Researchers from the University of Birmingham have identified an important new way in which our immune systems are regulated, and hope that understanding it will help tackle the debilitating effects of type 1 diabetes, rheumatoid arthritis and other serious diseases.
The team discovered a novel pathway that regulates the movement of pathogenic immune cells from the blood into tissue during an inflammatory response.
A healthy, efficient immune system ordinarily works to damp down inflammation and carefully regulate the magnitude of the response to infection and disease. ...
A University of Texas at Austin scientist, working with an international research team, has developed the most precise sequence map yet of U.S. cotton and will soon create an even more detailed map for navigating the complex cotton genome. The finding may help lead to an inexpensive version of American cotton that rivals the quality of luxurious Egyptian cotton and helps develop crops that use less water and fewer pesticides for a cotton that is easier on the skin and easier on the land.
Z. Jeffrey Chen and his collaborators, Tianzhen Zhang and Wangzhen Guo at Nanjing ...
